Biphenyl

Biphenyl

SCHEMBL3924499

C1CCC(C2CCCCC2)CC1.N.[LiH]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.73
SLC18A3 Q16572 1/20 0.36
HSD17B10 Q99714 1/20 0.35
HSD11B1 P28845 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
THRB P10828 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
EPHX1 P07099 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27750005 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL1579788 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Ammonia Solution, Strong SCHEMBL27529417 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Ammonia Solution, Strong SCHEMBL16004680 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL6278085 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL19245 0.95 ALDH1A1 (0.80) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL8628717 0.91 ALDH1A1 (0.73) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL7916980 0.91 ALDH1A1 (0.73) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL410566 0.91 ALDH1A1 (0.73) ALDH1A1SLC18A3HSD17B10HSD11B1CES2
Biphenyl SCHEMBL2997707 0.91 ALDH1A1 (0.89) ALDH1A1SLC18A3HSD17B10HSD11B1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007259-A1 PROCESS FOR THE PREPARATION OF AN INDOLE DERIVATIVE F. HOFFMANN-LA ROCHE AG (CH) 2009-01-15 WO disclosed
US-20090012311-A1 PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES F. HOFFMAN-LA ROCHE AG (CH) 2009-01-08 US disclosed
EP-2011783-A1 Process for the preparation of an indole derivative F. HOFFMANN-LA ROCHE AG (CH) 2009-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012311-A1 PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES IDO1, IDO2, TPH1 ALDH1A1 263/4885SLC18A3 483/4885HSD17B10 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.